.
MergerLinks Header Logo

Announced

Completed

Bain-Capital-backed Centrient Pharmaceuticals completed the acquisition of Astral SteriTech.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Cross Border

Friendly

India

Single Bidder

Majority

Pharmaceuticals

pharmaceutical company

Private

Completed

Synopsis

Edit

Bain-Capital-backed Centrient Pharmaceuticals, a manufacturer of beta-lactam antibiotics, completed the acquisition of Astral SteriTech, an international contract manufacturer specialized in sterile antibiotic powder injectable finished dosage forms. Financial terms were not disclosed. "The acquisition of Astral SteriTech is a significant step forward on the journey we at Centrient have undertaken to become the preferred commercial partner to our customers in Semi-Synthetic Cephalosporin and Semi-Synthetic Penicillin antibiotics," Rex Clements, Centrient CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US